|Min SIP Amount||Not Supported|
|NAV||₹11.23 (15 Jan 2021)|
|Fund Started||08 Feb 2017|
|Fund Size||₹78 Cr|
|Gland Pharma Ltd.||Healthcare||Equity||5.2%|
|Navin Fluorine International Ltd.||Chemicals||Equity||4.6%|
|India Cements Ltd.||Construction||Equity||3.1%|
|Grindwell Norton Ltd.||Metals||Equity||2.9%|
|JK Cement Ltd||Construction||Equity||2.9%|
|Equitas Small Finance Bank Ltd.||Financial||Equity||2.7%|
|INOX Leisure Ltd.||Services||Equity||2.7%|
|Phoenix Mills Ltd.||Construction||Equity||2.7%|
|Astra Microwave Products Ltd.||Communication||Equity||2.5%|
|Happiest Minds Technologies Ltd.||Technology||Equity||2.4%|
Sundaram Select Micro Cap Series XII Direct Growth is a Equity Mutual Fund Scheme launched by Sundaram Mutual Fund. This scheme was made available to investors on 08 Feb 2017. S Krishnakumar, Dwijendra Srivastava is the Current Fund Manager of Sundaram Select Micro Cap Series XII Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹78 Cr and the Latest NAV as of 15 Jan 2021 is ₹11.23.
The Sundaram Select Micro Cap Series XII Direct Growth is rated Moderately High risk.
The scheme seeks capital appreciation by investing predominantly in equity/equity-related instruments of companies that can be termed as micro-caps. A company whose market capitalisation is equal to or lower than that of the 301st stock by market cap on the NSE at the time of investment will be considered to be in micro-cap category.